In conclusion, DDR defects can increase the expression of tumor neoantigens, activate IFN response and enhance CD8+ T-cell-mediated specific antitumor immune response, and in some cases upregulate the expression of PD-L1. This evidence concerns the gene CD8A and neoplasm.